Quantitative Investment Management’s Travere Therapeutics TVTX Stock Holding History

Quantitative Investment Management’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-24,300	Closed	-$662K	–	878
2018 Q2	$662K	Sell	24,300 -6,600	-21%	-$176K	0.01%	564
2018 Q1	$690K	Sell	30,900 -15,300	-33%	-$364K	0.01%	617
2017 Q4	$973K	Sell	46,200 -42,500	-48%	-$971K	0.01%	605
2017 Q3	$2.21M	Buy	+88,700	New	+$1.95M	0.03%	479
2016 Q4	–	Sell	-15,800	Closed	-$353K	–	960
2016 Q3	$353K	Buy	+15,800	New	+$301K	0.01%	578
2016 Q2	–	Sell	-15,200	Closed	-$207K	–	929
2016 Q1	$207K	Buy	+15,200	New	+$231K	0.01%	694
2015 Q4	–	Sell	-32,800	Closed	-$664K	–	846
2015 Q3	$664K	Buy	+32,800	New	+$972K	0.05%	385

Other funds holding TVTX

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantitative Investment Management's TVTX Position: Q3 2018 in Review

Quantitative Investment Management sold out of Travere Therapeutics (TVTX) in Q3 2018, closing a stake of 24,300 shares — an estimated $662K sold.

Quantitative Investment Management first reported a position in TVTX in Q3 2015 and held it in 7 quarters. The position peaked at $2.21M in Q3 2017. 128 funds tracked by Wall St. Rank hold TVTX as of Q3 2018.

Quantitative Investment Management reported no remaining Travere Therapeutics position as of Q3 2018 after selling out during the quarter.
Quantitative Investment Management sold 24,300 Travere Therapeutics shares in Q3 2018, an estimated $662K.
Quantitative Investment Management first reported a position in Travere Therapeutics in Q3 2015 and held it in 7 quarters.
Quantitative Investment Management's Travere Therapeutics position peaked at $2.21M in Q3 2017.
128 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2018.

Based on Quantitative Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.